Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Credit agrmnt [a]
RESMED INC (RMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023"
04/27/2023 8-K Quarterly results
01/26/2023 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023",
"ResMed appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to become Chair Emeritus"
11/17/2022 8-K Quarterly results
10/27/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/14/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/28/2022 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022"
01/27/2022 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022"
11/19/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
10/28/2021 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022"
09/13/2021 8-K Quarterly results
08/27/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
04/29/2021 8-K Quarterly results
01/28/2021 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021"
11/20/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
10/29/2020 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2021"
08/05/2020 8-K Quarterly results
04/30/2020 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020"
02/26/2020 8-K Quarterly results
01/30/2020 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2020"
11/22/2019 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
10/24/2019 8-K Quarterly results
07/25/2019 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "Press Release regarding results of operations",
"ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019"
07/15/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Note Purchase Agreement, among ResMed Inc. and the purchasers parties to that that agreement (including form of 3.24% Series A Senior Note due 2026, form of Series B 3.45% Senior Note due 2029, and form of Subsidiary Guaranty Agreement)",
"Note Purchase Agreement, among ResMed Inc. and the purchasers parties to that that agreement (including form of 3.24% Series A Senior Note due 2026, form of Series B 3.45% Senior Note due 2029, and form of Subsidiary Guaranty Agreement)"
05/16/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : May 16, 2019 ResMed Inc. Delaware 001-15317 98-0152841 9001 Spectrum Center Blvd. San Diego, California 92123 836-5000 Registrant's Telephone Number, Including Area Code Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communication pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communication ..."
05/02/2019 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Under Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 2, 2019 ResMed Inc. Delaware 001-15317 98-0152841 9001 Spectrum Center Blvd. San Diego, California 92123 836-5000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Indicate by check m...",
"ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019"
01/24/2019 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Under Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : January 24, 2019 ResMed Inc. Delaware 001-15317 98-0152841 9001 Spectrum Center Blvd. San Diego, California 92123 836-5000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Indicate by ch...",
"ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2019"
11/16/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
11/14/2018 8-K Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 November 13, 2018 Date of Report ResMed Inc. Delaware 001-15317 98-0152841 9001 Spectrum Center Boulevard San Diego, California 92123 836-5000 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Ex...",
"ResMed Completes Acquisition of MatrixCare"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy